Location History:
- Guiseley, GB (1990)
- Leeds, GB (1991)
- Guiseley, Leeds LS20 8JN, GB (1991)
Company Filing History:
2 out of 2 
1 out of 832,912 Years Active: 1990-1991
Title: The Innovative Contributions of Brian W Barry
Introduction
Brian W Barry is a notable inventor based in Guiseley, GB. He has made significant contributions to the field of pharmacology through his innovative formulations. With a total of 3 patents to his name, Barry's work focuses on improving the delivery and effectiveness of pharmacologically active substances.
Latest Patents
Barry's latest patents include advancements in sustained-release and controlled-release formulations. The sustained-release formulation patent describes a granular sustained-release formulation presented in the form of a tablet. This tablet comprises sufficient granules to provide a predetermined dose of the pharmacologically active substance, along with effervescent or water-dispersible ingredients. Each granule has a diameter of preferably between 0.5 and 2.5 mm.
The controlled-release formulation patent addresses the challenge of poor aqueous solubility in pharmacologically active substances. This formulation includes granules that provide a predetermined dose, with each granule comprising 100 parts of the active substance and typically from 20 to 400 parts of carbomer. The granules may also be coated with a water-insoluble but water-swellable acrylic polymer, enhancing their effectiveness.
Career Highlights
Throughout his career, Barry has worked with various companies, including Aps Research Limited. His experience in the industry has allowed him to develop innovative solutions that address critical challenges in drug formulation.
Collaborations
Barry has collaborated with notable individuals in his field, including Bryan A Mulley and Peter York. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Brian W Barry's contributions to pharmacological formulations demonstrate his commitment to innovation and improvement in drug delivery systems. His patents reflect a deep understanding of the complexities involved in creating effective medications.